1. Home
  2. ABEO vs FLXS Comparison

ABEO vs FLXS Comparison

Compare ABEO & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • FLXS
  • Stock Information
  • Founded
  • ABEO N/A
  • FLXS 2001
  • Country
  • ABEO United States
  • FLXS United States
  • Employees
  • ABEO N/A
  • FLXS N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • FLXS Home Furnishings
  • Sector
  • ABEO Health Care
  • FLXS Consumer Discretionary
  • Exchange
  • ABEO Nasdaq
  • FLXS Nasdaq
  • Market Cap
  • ABEO 237.4M
  • FLXS 221.4M
  • IPO Year
  • ABEO 1980
  • FLXS N/A
  • Fundamental
  • Price
  • ABEO $4.92
  • FLXS $31.94
  • Analyst Decision
  • ABEO Strong Buy
  • FLXS
  • Analyst Count
  • ABEO 5
  • FLXS 0
  • Target Price
  • ABEO $17.00
  • FLXS N/A
  • AVG Volume (30 Days)
  • ABEO 834.1K
  • FLXS 17.3K
  • Earning Date
  • ABEO 05-14-2025
  • FLXS 04-21-2025
  • Dividend Yield
  • ABEO N/A
  • FLXS 2.18%
  • EPS Growth
  • ABEO N/A
  • FLXS 23.30
  • EPS
  • ABEO N/A
  • FLXS 3.55
  • Revenue
  • ABEO N/A
  • FLXS $430,531,000.00
  • Revenue This Year
  • ABEO N/A
  • FLXS $8.73
  • Revenue Next Year
  • ABEO $539.93
  • FLXS $5.13
  • P/E Ratio
  • ABEO N/A
  • FLXS $8.80
  • Revenue Growth
  • ABEO N/A
  • FLXS 7.75
  • 52 Week Low
  • ABEO $3.05
  • FLXS $28.81
  • 52 Week High
  • ABEO $8.45
  • FLXS $65.87
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 51.29
  • FLXS 33.89
  • Support Level
  • ABEO $3.93
  • FLXS $31.19
  • Resistance Level
  • ABEO $5.02
  • FLXS $33.05
  • Average True Range (ATR)
  • ABEO 0.41
  • FLXS 2.25
  • MACD
  • ABEO 0.06
  • FLXS 0.00
  • Stochastic Oscillator
  • ABEO 90.83
  • FLXS 15.87

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: